Single- and multiple-dose pharmacokinetics of inhaled indacaterol in healthy Chinese volunteers
Indacaterol is an inhaled, ultra–long-acting β2-agonist that provides 24-h bronchodilation with once-daily dosing in patients with chronic obstructive pulmonary disorder. This study evaluated the pharmacokinetics, safety, and tolerability of multiple daily inhaled doses of indacaterol 150 or 300 μg...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426132/ |